Maiden Pharmaceuticals

Solan, India Founded: 1990 • Age: 36 yrs
Manufacturer of drugs

About Maiden Pharmaceuticals

Maiden Pharmaceuticals is a Healthcare company based in Solan (India) founded in 1990. Manufacturer of drugs. It operates on a Traditional Pharmaceuticals model. Its Indian entity Cureclip Pharmaceuticals Limited reported revenue of β‚Ή39.2 Lakh. Maiden Pharmaceuticals offers products and services including Maiden Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals.

Company details

Maiden Pharmaceuticals offers Maiden Pharmaceuticals Platform while focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of drugs. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹39.2 Lakh

    FY 2025 · -94% YoY

  • Net Loss
    -₹62 Lakh

    FY 2025 · -158% margin

  • EBITDA
    ₹16.9 Lakh

    FY 2025 · 43% margin

Products & Services of Maiden Pharmaceuticals

Maiden Pharmaceuticals offers a comprehensive portfolio of products and services, including Maiden Pharmaceuticals Platform.

Maiden Pharmaceuticals Platform
Healthcare

Manufacturer of drugs

Board of directors of Cureclip Pharmaceuticals Limited (Maiden Pharmaceuticals)

Cureclip Pharmaceuticals Limited is the primary company behind Maiden Pharmaceuticals. The board of Cureclip Pharmaceuticals Limited currently have 3 directors; the longest-serving is Naresh Kumar Goyal, appointed in 2005. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Naresh Kumar Goyal
DIN 00135922
Director01 Nov 200521 yrsCureclip Pharmaceuticals Limited
Vivek Goyal
DIN 01882927
Director15 Dec 20169 yrs 10 moCureclip Pharmaceuticals Limited
Manoj Kumar Jha
DIN 10776701
Additional Director01 Apr 20251 yr 7 moCureclip Pharmaceuticals Limited

Financials of Maiden Pharmaceuticals

Figures of Cureclip Pharmaceuticals Limited, the primary company behind Maiden Pharmaceuticals, for FY 2025. Revenue was ₹39.2 Lakh (-94% year on year). Net loss was -₹62 Lakh (-158% margin). EBITDA was ₹16.9 Lakh (43% margin). Revenue has grown at a compounded annual rate of -79% over three years and -59% over five years.

  • ₹39.2 LakhRevenue · FY 2025 · -94% YoY
  • -₹62 LakhNet loss · -158% margin
  • ₹16.9 LakhEBITDA · 43% margin
  • ₹57.3 LakhPaid-up capital
  • -79%Revenue CAGR, 3 years
  • -59%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cureclip Pharmaceuticals Limited are on its company page.

Premium access

Detailed financial statements for Maiden Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Maiden Pharmaceuticals

Premium access

Complete news archive for Maiden Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maiden Pharmaceuticals

Maiden Pharmaceuticals was founded in 1990.

Maiden Pharmaceuticals is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.

The primary company behind Maiden Pharmaceuticals, Cureclip Pharmaceuticals Limited, reported revenue of β‚Ή39.2 Lakh for FY 2025, down 94% year on year.

Maiden Pharmaceuticals offers Maiden Pharmaceuticals Platform while focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of drugs. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs. It continues to evolve, meeting industry challenges with strategic approaches.

Maiden Pharmaceuticals offers Maiden Pharmaceuticals Platform.

Maiden Pharmaceuticals operates through Cureclip Pharmaceuticals Limited.

The legal entities of Maiden Pharmaceuticals currently have 3 directors, including Vivek Goyal, Naresh Kumar Goyal, Manoj Kumar Jha.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available